International Journal of Gynecological Cancer
IF
2.10
Papers
6385
Papers 6797
1 page of 680 pages (6,797 results)
Newest
#2Allison Gockley (Harvard University)H-Index: 10
Last. Michael J. Worley (Harvard University)H-Index: 15
view all 10 authors...
OBJECTIVE To evaluate the impact of size and distribution of residual disease after interval debulking surgery on the timing and patterns of recurrence for patients with advanced-stage epithelial ovarian cancer. METHODS Patient demographics and data on disease treatment/recurrence were collected from medical records of patients with stage IIIC/IV epithelial ovarian cancer who were managed with neoadjuvant chemotherapy/interval debulking surgery between January 2010 and December 2014. Among patie...
Source
Objective null COVID-19 is a global public health emergency. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological tumors. The Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) performed a survey to evaluate the impact of the COVID-19 pandemic on medical treatment of gynecological cancer, with a focus on chemotherapy and oral treatment with poly(ADP)-ribose polymerase inhibitors (PARP-i). null Methods null The su...
Source
#1Dirk TimmermanH-Index: 80
#2David Cibula (First Faculty of Medicine, Charles University in Prague)H-Index: 59
Last. Daniela Fisherova (First Faculty of Medicine, Charles University in Prague)H-Index: 1
view all 20 authors...
We thank Isabelle Thomassin-Nagarra et al for their interest in the ESGO/ISUOG/IOTA/ESGE consensus statement on the pre-operative diagnosis of ovarian tumors. This statement is based on a careful review of the relevant literature and available evidence as well as on structured discussions between
Source
#1Isabelle Thomassin-Naggara (University of Paris)H-Index: 20
Last. Caroline Reinhold (MUHC: McGill University Health Centre)H-Index: 10
view all 4 authors...
We read with much interest the consensus paper by Timmerman et al[1][1] on the pre-operative diagnosis of ovarian tumors, which included representatives from ESGO/ISUOG/IOTA/ESGE. Although the paper details the important value of ultrasonography in this clinical setting, it does not adequately
Source
#1H Azaïs (University of Paris)H-Index: 4
#2Meriem Koual (University of Paris)H-Index: 2
Last. Anne-Sophie Bats (University of Paris)H-Index: 24
view all 6 authors...
The objective of the video article is to present a complete robotic restaging surgery for an early stage endometrioid ovarian cancer developed in an endometrioma in a young patient wishing to preserve her fertility. We demonstrate the entire surgical technique of restaging. Institutional review
Source
#1Christina Fotopoulou (Imperial College London)H-Index: 20
#2François PlanchampH-Index: 13
Last. Catherine Hughes (Imperial College London)H-Index: 4
view all 19 authors...
The European Society of Gynaecological Oncology (ESGO) developed and established for the first time in 2016, and updated in 2020, quality indicators for advanced ovarian cancer surgery to audit and improve clinical practice in Europe and beyond. As a sequela of the continuous effort to improve oncologic care in patients with ovarian cancer, ESGO issued in 2018 a consensus guidance jointly with the European Society of Medical Oncology addressing in a multidisciplinary fashion 20 selected key ques...
Source
#1Pedro T. Ramirez (University of Texas MD Anderson Cancer Center)H-Index: 66
In select patients with advanced ovarian cancer, primary cytoreductive surgery remains a standard approach with the aim of complete resection of all gross visible tumor.[1][1] Prior data have demonstrated that survival outcomes are driven by geographical access and the use of specialized referral
Source
#1Alli M. Straubhar (UofU: University of Utah)H-Index: 3
#2Matthew Parsons (HCI: Huntsman Cancer Institute)H-Index: 4
Last. Kathryn A. Maurer (UofU: University of Utah)H-Index: 3
view all 5 authors...
OBJECTIVES The goal of this study was to determine the impact refusal of surgery has on overall survival in patients with endometrial cancer. METHODS From January 2004 to December 2015, the National Cancer Database was queried for patients with pathologically proven endometrial cancer who were recommended surgery and refused. Inverse probability of treatment weighting was used to account for differences in baseline characteristics between patients who underwent surgery and those who refused. Kap...
Source
#1Cihan Comba (UHSA: University of Health Sciences Antigua)H-Index: 2
#2Gökhan Demirayak (Health Science University)H-Index: 6
Last. İsa Aykut Özdemir (Istanbul Medipol University)H-Index: 6
view all 5 authors...
Endometrial cancer (EC) is the most common gynecological malignancy. Although EC is surgically staged, sentinel lymph node biopsy has become more widely used and has been featured in recently published guidelines for EC.[1][1] Randomized trials have shown that minimally invasive approaches to EC
Source
Objective null Cervical cancer is the fourth most frequent neoplasm among women in terms of incidence and mortality. Health-related quality of life (HRQL) is an important outcome in oncology. The QLQ-CX24 instrument was developed to measure HRQL in patients with cervical cancer, and its Mexican-Spanish version had not been validated. null Methods null Between March 2018 and May 2019, Mexican women older than 18, with any-stage cervical cancer were invited to participate in the study. Patients an...
Source
12345678910
Top fields of study
Cancer
Surgery
Oncology
Cervical cancer
Ovarian cancer
Gynecology
General surgery
Medicine